One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-145723
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 5 |
Affiliation: Bristol-Myers Squibb (United States), Moffitt Cancer Center, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Université Paris Cité, University Hospital Leipzig, Yale Cancer Center, The University of Texas MD Anderson Cancer Center, University of Florence, Bristol-Myers Squibb (Switzerland), Sunnybrook Health Science Centre, Health Sciences CentreAnalysis of Duration of Response, Exposure-Adjusted Safety and Progression to Acute Myeloid Leukemia (AML) for Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Receiving Luspatercept in the MEDALIST Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
